IBM and New York Genome Center to collaborate using Watson technology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

IBM and the New York Genome Center will collaborate on a comprehensive and open repository of genetic data to accelerate cancer research, using Watson technology. The collaboration was announced at the White House’s Precision Medicine Initiative Summit. IBM and the center will build the capacity to house the contributed data, train Watson’s cognitive computing capabilities...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The landscape of cancer care in America faces critical challenges: geographic disparities in access, socioeconomic barriers to advanced treatments and the increasing complexity of precision medicine that outpaces individual providers’ ability to stay current. At City of Hope, we are addressing these systemic issues through a bold expansion that brings world-class cancer care and research closer to where patients live.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login